ilShinBioBase Co

ilShinBioBase Co Equity Growth

The Year-over-Year Equity Growth of ilShinBioBase Co (068330.KQ) as of Nov 11, 2026 is 7.19 %. In the previous year, Year-over-Year Equity Growth was 5.93 % — a change of 21.19% (higher).

Equity Growth

7.19 %

YoY

21.19%

Last updated:

Year-over-Year Equity Growth of ilShinBioBase Co is 2025 7.19 % . Year-over-Year Equity Growth of ilShinBioBase Co was 2024 5.93 % . It decreases by 21.19% higher compared to the previous year.

The ilShinBioBase Co Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
1.41 KRW
Jan 1, 2019
12.44 KRW
Jan 1, 2020
10.51 KRW
Jan 1, 2021
13.72 KRW
Jan 1, 2022
6.64 KRW
Jan 1, 2023
6.03 KRW
Jan 1, 2024
5.93 KRW
Jan 1, 2025
7.19 KRW
The ilShinBioBase Co Equity Growth history
YEAREquity GrowthYoY
7.19 %+21.19%
5.93 %-1.59%
6.03 %-9.23%
6.64 %-51.58%
13.72 %+30.56%
10.51 %-15.55%
12.44 %+785.16%
1.41 %-79.28%
6.78 %-81.00%
35.71 %+8,972.12%
0.39 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ilShinBioBase Co Stock analysis

What does ilShinBioBase Co do? ilShinbiobase Co., Ltd. generates revenue by manufacturing and distributing industrial refrigeration equipment. Its product portfolio includes freeze dryers for drying sera, antibiotics, enzymes, laboratory samples, and foods; programmable freeze dryers for early-stage research with temperature, time, and vacuum control; deep freezers for biotechnology applications; and ice makers for research laboratories. The company also offers blood bank refrigerators, pharmaceutical refrigerators, shakers, and food processing equipment. These products are sold domestically and to overseas markets, targeting biotechnology firms, pharmaceutical companies, research institutions, and laboratories requiring specialized refrigeration solutions. The company's revenue streams primarily come from the sale of its industrial refrigeration equipment to customers in the biotechnology, pharmaceutical, and research sectors. Products like programmable freeze dryers and deep freezers are specifically designed for early-stage research and biotechnology applications, catering to the needs of laboratories and biotech firms. Blood bank refrigerators and pharmaceutical refrigerators serve healthcare and pharmaceutical industries, while ice makers and food processing equipment support research and food-related applications. ilShinbiobase’s business model focuses on providing specialized refrigeration equipment for niche markets. The company targets biotechnology and pharmaceutical industries with deep freezers and blood bank refrigerators, while programmable freeze dryers and shakers are marketed to research laboratories. Overseas and domestic distribution channels ensure market reach, with products tailored to specific industry requirements such as serum drying in pharmaceuticals and sample preservation in laboratories. ilShinBioBase Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ilShinBioBase Co stock

Year-over-Year Equity Growth of ilShinBioBase Co is 7.19 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth ilShinBioBase Co since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's ilShinBioBase Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — ilShinBioBase Co

All Key Metrics — ilShinBioBase Co